ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
1-Year Est. Return
11.37%
1 Year Est. Return
+11.37%
AUM
$6.41B
AUM Growth
-$663M
(-9.4%)
Holding
40
Top Buys
| 1 | +$236M | |
| 2 | +$58.2M | |
| 3 | +$36.8M | |
| 4 |
Kymera Therapeutics
KYMR
|
+$35.9M |
| 5 |
Krystal Biotech
KRYS
|
+$18.4M |
Top Sells
| 1 | +$320M | |
| 2 | +$96.1M | |
| 3 | +$30.1M | |
| 4 |
United Therapeutics
UTHR
|
+$26.3M |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$25.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$19.6B
| $825M | 12.87% |
2,675,000
-85,300
|
|
||
2
Ascendis Pharma
ASND
$12.5B
| $813M | 12.69% |
5,218,000
+114,945
|
|
||
3
argenx
ARGX
$50.1B
| $731M | 11.41% |
1,235,177
-3,290
|
|
||
4
Madrigal Pharmaceuticals
MDGL
$9.66B
| $670M | 10.46% |
2,022,222
-6,778
|
|
||
|
5
Krystal Biotech
KRYS
$5.44B
| $492M | 7.69% |
2,731,000
+102,178
|
|
||
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $341M | 5.32% |
3,850,000
+2,665,000
|
|
||
7
Apellis Pharmaceuticals
APLS
$2.92B
| $267M | 4.17% |
12,222,222
|
|
||
8
Avidity Biosciences
RNA
$7.02B
| $225M | 3.51% |
7,625,000
+125,000
|
|
||
9
Xenon Pharmaceuticals
XENE
$3.23B
| $193M | 3.01% |
5,741,666
+75,000
|
|
||
10
Soleno Therapeutics
SLNO
$3.38B
| $180M | 2.82% |
2,525,000
|
|
||
|
11
Kymera Therapeutics
KYMR
$4.17B
| $177M | 2.76% |
6,460,000
+1,310,000
|
|
||
12
Sarepta Therapeutics
SRPT
$2.32B
| $171M | 2.66% |
2,674,835
+119,280
|
|
||
13
Amicus Therapeutics
FOLD
$2.48B
| $167M | 2.61% |
20,500,000
-2,675,000
|
|
||
14
Arrowhead Research
ARWR
$4.97B
| $142M | 2.21% |
11,111,111
|
|
||
15
Vera Therapeutics
VERA
$1.93B
| $137M | 2.14% |
5,701,900
+91,900
|
|
||
16
Merus
MRUS
$7.19B
| $126M | 1.97% |
3,000,000
+875,000
|
|
||
17
MoonLake Immunotherapeutics
MLTX
$628M
| $108M | 1.69% |
2,770,100
|
|
||
|
ITCI
18
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $82.5M | 1.29% |
625,000
-2,425,000
|
|
||
19
Alkermes
ALKS
$5.27B
| $80.9M | 1.26% |
2,450,000
|
|
||
20
BioCryst Pharmaceuticals
BCRX
$1.35B
| $65.3M | 1.02% |
8,700,000
-3,165,000
|
|
||
21
Ocular Therapeutix
OCUL
$2.38B
| $59.1M | 0.92% |
8,060,000
|
|
||
|
CNTA
22
Centessa Pharmaceuticals
CNTA
$3B
| $58.2M | 0.91% |
+4,050,000
|
|
||
23
89bio
ETNB
$2.2B
| $46.2M | 0.72% |
6,350,000
+2,250,000
|
|
||
24
MannKind Corp
MNKD
$1.56B
| $44M | 0.69% |
8,750,000
|
|
||
25
Vaxcyte
PCVX
$5.56B
| $37.8M | 0.59% |
1,000,000
-175,000
|
|